U.S., July 24 -- ClinicalTrials.gov registry received information related to the study (NCT07079852) titled 'The Acute Effects of Psilocybin on Cognition, Memory, and Brain Function' on July 10.
Brief Summary: This study will test the effects of psilocybin on memory and cognition in healthy participants using computerized tasks and magnetic resonance imaging (MRI).
Study Start Date: Sept., 2025
Study Type: INTERVENTIONAL
Condition:
Healthy
Intervention:
DRUG: Placebo
This is an inactive control condition.
DRUG: Psilocybin 15mg
This is a moderate psychoactive dose.
Recruitment Status: NOT_YET_RECRUITING
Sponsor: Manoj Doss
Information provided by (Responsible Party): Manoj Doss, University of Texas at Austin
Disclaimer: Curated...